| |
|
|
|
|
|
SEPS Pharma intends to enlarge its pipeline by in-licensing promising compounds and advances these projects through the clinical testing stage. SEPS Pharma's experienced management team, Hasselt University (BIOMED), the scientific advisory board and the board of directors apply a detailed screening process. SEPS Pharma designs a comprehensive drug development plan and assumes full responsibility for its progress and success. Throughout the process, SEPS Pharma strives to maintain strong involvement of the out-licensing partner in the drug development program.
SEPS Pharma is continuously seeking new therapeutic projects for a wide array of indications.
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
